Form 4: HealthStream CTO Boosts Stake Through RSU Vesting
Insider Transaction Report
HealthStream's Chief Technology Officer, Jeff Cunningham, increased his direct common stock ownership following the vesting of restricted share units.
Summary
- Jeff Cunningham, Chief Technology Officer of HealthStream Inc. (HSTM), reported transactions on September 29, 2025.
- He acquired 869 shares of common stock through the vesting of restricted share units (RSUs) at a price of $0 per share.
- Concurrently, 212 shares were disposed of at a price of $29.08 per share to cover tax liabilities associated with the RSU vesting.
- Following these transactions, Cunningham directly beneficially owns 33,010 shares of common stock.
- He also holds 1,828 and 1,741 restricted share units, respectively, which are subject to future vesting schedules.
Sentiment
Score: 6
Explanation: The filing indicates a routine insider transaction involving RSU vesting and tax-related share disposal. While there's a net increase in direct ownership, the overall impact is neutral to slightly positive as it reflects standard compensation practices rather than a discretionary open market purchase.
Positives
- Jeff Cunningham's direct beneficial ownership of HealthStream common stock increased by a net of 657 shares (869 acquired 212 disposed for tax) following the RSU vesting.
- The acquisition of shares through RSU vesting demonstrates continued alignment of management's interests with shareholders.
Negatives
- 212 shares were disposed of to cover tax liabilities, representing a reduction in direct ownership for that specific purpose.
Future Outlook
Remaining restricted share units are subject to multi-year vesting schedules, contingent upon continued service, with future vesting dates extending through September 2028.
Industry Context
This filing represents a routine insider transaction related to executive compensation, common across publicly traded companies in various industries, including healthcare technology.
Stakeholder Impact
- Shareholders: A minor, routine increase in insider ownership, aligning management incentives with shareholder value over the long term.
Next Steps
- Future vesting of remaining Restricted Share Units on scheduled dates through September 2028.
Key Dates
| Date | Description |
|---|---|
| 09/20/2024 | 15% vesting of certain Restricted Share Units (RSUs). |
| 09/18/2025 | 15% vesting of certain Restricted Share Units (RSUs). |
| 09/20/2025 | 20% vesting of certain Restricted Share Units (RSUs). |
| 09/29/2025 | Date of reported transactions, including RSU vesting, common stock acquisition, and tax withholding. |
| 09/18/2026 | 20% vesting of certain Restricted Share Units (RSUs). |
| 09/20/2026 | 30% vesting of certain Restricted Share Units (RSUs). |
| 09/18/2027 | 30% vesting of certain Restricted Share Units (RSUs). |
| 09/20/2027 | 35% vesting of certain Restricted Share Units (RSUs). |
| 09/18/2028 | 35% vesting of certain Restricted Share Units (RSUs). |
Recommendation
holdThis Form 4 details routine vesting and tax-related share disposals by a Chief Technology Officer. It does not present new information that would fundamentally alter the investment thesis for HealthStream Inc., thus a 'hold' recommendation is appropriate for existing investors. The transactions are expected and do not signal a significant change in company prospects or insider sentiment beyond standard compensation.
Keywords
HealthStream, HSTM, Jeff Cunningham, Chief Technology Officer, Insider Transaction, Form 4, Restricted Share Units, RSU Vesting, Common Stock, Share Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.